SAR422459

· Sanofi

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SAR422459, covering 2020-06-05 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration [Phase 2]